SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-23-046335
Filing Date
2023-10-02
Accepted
2023-10-02 16:45:19
Documents
12
Period of Report
2023-09-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20011676_8k.htm   iXBRL 8-K 30413
  Complete submission text file 0001140361-23-046335.txt   165766

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA adma-20230928.xsd EX-101.SCH 3880
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE adma-20230928_lab.xml EX-101.LAB 22546
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adma-20230928_pre.xml EX-101.PRE 16054
6 EXTRACTED XBRL INSTANCE DOCUMENT ef20011676_8k_htm.xml XML 4030
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Filer) CIK: 0001368514 (see all company filings)

IRS No.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36728 | Film No.: 231300317
SIC: 2836 Biological Products, (No Diagnostic Substances)